 

 

 

 

UUID:gtéegﬁfééilggagsgiﬁﬁg-F18CC13C3|718é a ct ed
Ill IllllIllIllIllllllllllllllIllllllHllllllllllllllllllll||||||||| m APPROVED
lllI llllll|l||ll|||||Illllllllll||||||||||IIl|I|||lIHIIIlI
iiiilllIillllllllllllllllllllllllllllllllllllllllllllllll Illl F9“, Revised
Clinical Case Report
1c :3 - a / 5 (For Collection of Cancerous Tissue)

0W WWCW N0; 9770/3
sSlh: W agave

I/ﬂ—l/J—

 

{Informed maﬁa

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

our institution. _

1‘

Signature

lilame of Physician or Study Coordinator Date

 

[Clinical Information]

 

 

 

 

 

 

 

 

GENERAL INFORMATION
Date of Birth (mmldd/yyyy) Height Marital Status Race l Temperature
' ‘ ‘ ‘ _ ‘ a Single TQMarried _ '
Gender Weight El Divorced Cl Widow Blood Pressure Heart Rate
ﬁMale DFemale w r, ,/ .L 2’]?

 

 

 

 

 

 

 

HISTORY OF PRESENT ILLNESS-I

 

Chief Complaints: Mim‘mﬂﬂ I'PW‘”

 

Symptoms: 52M at, ; \tregllemt/YS J w Gig/«d— L335

 

Clinical Findings:

 

Performance Scale (Karnofsky Score):
:1 100 Asymptomatic CI 80-90 Symptomatic but Fully Ambulatory

a 60-70 Symptomatic, in bed ‘less than 50% of day
:1 20-30 Bed Ridden

 

4940-50 Symptomatic, in bed more than 50% of day. but not bed ridden
\

CURRENT MEDICATIONS
Route

Dose

 

 

PAST MEDICAL HISTORY
Disease Disorder D

Date Status

 

 

 

 

El Post-menopausal

 

v OBIGYN HISTORY
-‘-- Menopausal Status Date of First Menses # of Preggancies
[J Pre—menopausal
Ci Peri-Menopausal Date of Last Menses # of Live Births

 

 

 

Birth control: DCondom UOral Contraceptive CJIUD

a Hormone Replacement

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

D Other: Therapy:‘
SOCIAL HISTORY
Occupation: 1 Environmental Hazards:
Smoking History
Current Status TYPE Packs] day Duration When Quit
eves 0N0 LP [W 50 (yrs) ' hm “gem
Alcohol Consumption ‘
Current Status TYPE Drinks/day Duration When Quit
3’ YES 0N0 LMC (Am ,« it" (yrs) ftmIﬂQ a, 5&2 gm
Drug Use '
Current Status TYPE Frequency Duration When Quit
U YES Ei/NO (yrs) (yr)

 

 

 

 

FAMILY MEDICAL HISTORY

 

 

 

LAB DATA

 

Test Result

Date v Test

Result Date

 

HIV ‘ﬁiNegative ClPositive:

 

CEA Cl Negative Cl Positive:

 

 

Hep B chegalive El Positive: ii CA 15-3 Cl Negative E] Positive:
Hep C ﬁNegative Cl Positive: [1 CA 19-9 :1 Negative Cl Positive:

 

AF P D Negative NPositive:

PSA U Negative Cl Positive:

 

Other:

 

D Negative El Positive:

I

Other:

 

 

 

 

CI Negative El Positive:

 

 

 

B/T Cell Markers:

 

 

DIAGNOSTIC STUDIES
Results

Ultrasound
X-Ra
CT
En
MRI
Bi

CAL DIAGNOSIS
Clinical

Location of Involved L Location of Distant

Clinical Date of
T NO M Stage: / ’

 

 

[Treatment Information}

SURGICAL TREATMENT
Procedure Date of

t s.

Prima Tumor
Detailed Location

Extension of Tumor

L Nodes
Location of l. Nodes # of L Nodes

Palpable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis
Detailed Location

T N M

NEOADJUVENT THERAPY or Molecular

Treatment Route Date
To

To
To
To
To

 

Pathology Form

 

lSpecimen Informationj

Date: ._ ‘ime:_

Collected by: M

.4

Preserved by: Date: . Time: L I .

 

 

SPECIMEN TYPE (# of samples provided)

 

 

 

 

 

 

 

 

 

 

Frozen Parafﬁn Block Blood/Serumll’lasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
4 Z /7' Z. 4: 2
Time to LN2 Time to Formalin Time to LNZ ‘
,/ 2 min /3’ min min

 

 

 

 

 

PATHOLOGICAL DESCRIPTION
Pri

Tumor
Size Distance to NAT
x 6’ x cm ‘ cm

Nodes
# Examined

Extension of Tumor

Location # Metastasized

Distant Metastasis
Detailed

 

 

lMicroscoEic Descriptionl

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Histological Pattern
Cell Distribution + - Structural Pattern + -

Diffuse >0 Streaming
Mosaic Storiform
Necrosis 7Q Fibrosis
Lymphocytic Infiltration T Palisading
Vascular Invasion Cystic Degeneration
Clusterized Bleeding
Alveolar Formation Myxoid Change
Indian File Psammoma/Calciﬂcatlon

Cellular Differentiation

Squamous + - Adenomatous + - Sarcomatous + - Lymphomatous + -
Squamoid Cell Glandular cell Round Cell Large Cell
Spindle Cell Cell Stratiﬁcation Fibroblast Small Cell
Keratin Secretion Osteoblast RS Cell/RS Like
Desmosome IntraQ/t. Vacuole Lipoblast Inflam. Cell
Pearl Gland formation Myoblast Plasma Cell
Cellular Differentiation: El Well [El Moderate El Poor
Nuclear Appearance
Nuclear A_typia: 0 I II III

Aniso Nucleosis so
Hyperchromatism y'
Nucleolar Prominent Z’
Multinucleated Giant Cell )-
Mitotic Activity 2"

Nuclear Grade:

 

 

 

 

 

 

IHC Data

Marker
ER
PR
Her— neu
B-Cell Marker
T Marker

D VB
El Positive
El ve
D Positive
:2

0 Positive
:3 Positive

0000000

Other:

 

 

{Final Pathology Renard

 

 

 

 

 

 

 

Histological Diagnosis: #9, m 7,19,07,49 ; ,7”) m3 -
l 27/! 00/10 Rafe /r.f off rye/@014 255375/ ) (,1 / L/Ud Mr) Grader /(
J // /
Comments:
- }
P‘rmcipal investigator — Pathologist E Date

CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM" '

“wimp“ Appearance:

1.

DISTRIBUTION

Ditl'nse
Mosaic

L

2. Cellular
+ ..

Ce“ Cell Stratiﬁcation

Gland

V

2. Cellular Diﬂ’emdatlnn:
Well M. sly Poor

 

 

 

 

 

 

 

 

Nuclear

 

' 5‘— L
Histological Diagnosis: Mei/'0 W 71W (’ MEL/91W I

 

Commem—
-— a” ”‘31::
Director. Research M
rsrsrm mu nestmar use cum.

0. «11101.06
*(JMEGRATED REPORT or FINDINGS or common AN

